Natera

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). 

CEO
Solomon Moshkevich
CEOSolomon Moshkevich
Employees
6,140
Employees6,140
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2003
Founded2003
Employees
6,140
Employees6,140

NTRA Key Statistics

Market cap
41.98B
Market cap41.98B
Price-Earnings ratio
-252.55
Price-Earnings ratio-252.55
Dividend yield
—
Dividend yield—
Average volume
2.50M
Average volume2.50M
High today
$291.50
High today$291.50
Low today
$277.50
Low today$277.50
Open price
$286.67
Open price$286.67
Volume
1.96M
Volume1.96M
52 Week high
$437.41
52 Week high$437.41
52 Week low
$181.00
52 Week low$181.00

Stock Snapshot

The current Natera(NTRA) stock price is $294.46, with a market capitalization of 41.98B. The stock trades at a price-to-earnings (P/E) ratio of -252.55.

On 2026-11-19, Natera(NTRA) stock traded between a low of $277.50 and a high of $291.50. Shares are currently priced at $294.46, which is +6.1% above the low and +1.0% below the high.

Natera(NTRA) shares are trading with a volume of 1.96M, against a daily average of 2.5M.

During the past year, Natera(NTRA) stock moved between $181.00 at its lowest and $437.41 at its peak.

During the past year, Natera(NTRA) stock moved between $181.00 at its lowest and $437.41 at its peak.

NTRA News

TipRanks 21h
Natera price target lowered to $350 from $363.50 at Piper Sandler

Piper Sandler lowered the firm’s price target on Natera (NTRA) to $350 from $363.50 following quarterly results. The firm keeps an Overweight rating on the shar...

Simply Wall St 2d
Natera Maps Signatera Growth, Is It Still 30% Below Fair Value?

Natera (NTRA) has moved into focus after its CFO outlined a multi year revenue plan centered on the Signatera cancer testing franchise, tying that roadmap to re...

Natera Maps Signatera Growth, Is It Still 30% Below Fair Value?
TipRanks 4d
Natera Earnings Call Highlights Growth and Margin Gains

Natera Inc. ((NTRA)) has held its Q3 earnings call. Read on for the main highlights of the call. Natera delivered a strongly positive quarter, marked by record...

Analyst ratings

88%

of 24 ratings
Buy
87.5%
Hold
8.3%
Sell
4.2%

More NTRA News

Benzinga 6d
Micron, Moody’s, Digital Realty and a Health Care Stock on CNBC’s ‘Final Trades’

On CNBC’s “Halftime Report Final Trades,” Bill Baruch, founder and CIO of both Blue Line Capital and Blue Creek Capital Management, picked Micron Technology, In...

Micron, Moody’s, Digital Realty and a Health Care Stock on CNBC’s ‘Final Trades’
Simply Wall St 6d
Why Is Natera Expanding Signatera’s Role In A Phase II Cancer Trial?

Natera (NasdaqGS:NTRA) and Incyte announced a clinical collaboration using Signatera in a Phase II colorectal cancer immunotherapy trial. The study will use Si...

Why Is Natera Expanding Signatera’s Role In A Phase II Cancer Trial?

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.